Dementias

Acrescent - Assessment Report, 2012 Aevarsson, 1996, A population-based study on the incidence of dementia disorders between 85 and 88 years of age, J Am Geriatr Soc, 44, 1455, 10.1111/j.1532-5415.1996.tb04070.x Aggarwal, 2005, Mild cognitive impairment in different functional domains and incident Alzheimer's disease, J Neurol Neurosurg Psychiatry, 76, 1479, 10.1136/jnnp.2004.053561 Aggarwal, 2006, The relation of cigarette smoking to incident Alzheimer's disease in a biracial urban community population, Neuroepidemiology, 26, 140, 10.1159/000091654 Alexopoulos, 2006, Progression to dementia in clinical subtypes of mild cognitive impairment, Dement Geriatr Cogn Disord, 22, 27, 10.1159/000093101 Alzheimer's Association, 2015, 2015 Alzheimer's disease facts and figures, Alzheimers Dement, 11, 332, 10.1016/j.jalz.2015.02.003 Amieva, 2004, Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study, Dement Geriatr Cogn Disord, 18, 87, 10.1159/000077815 Andreasen, 2005, CSF biomarkers for mild cognitive impairment and early Alzheimer's disease, Clin Neurol Neurosurg, 107, 165, 10.1016/j.clineuro.2004.10.011 Andreasen, 2003, Cerebrospinal fluid levels of total-tau, phospho-tau and A beta 42 predicts development of Alzheimer's disease in patients with mild cognitive impairment, Acta Neurol Scand Suppl, 179, 47, 10.1034/j.1600-0404.107.s179.9.x Anttila, 2004, Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study, BMJ, 329, 539, 10.1136/bmj.38181.418958.BE APA, 2013 Apostolova, 2008, Mapping progressive brain structural changes in early Alzheimer's disease and mild cognitive impairment, Neuropsychologia, 46, 1597, 10.1016/j.neuropsychologia.2007.10.026 Artero, 2006, Revised criteria for mild cognitive impairment: validation within a longitudinal population study, Dement Geriatr Cogn Disord, 22, 465, 10.1159/000096287 Bachman, 1993, Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study, Neurology, 43, 515, 10.1212/WNL.43.3_Part_1.515 Ballard, 2011, Alzheimer's disease, Lancet, 377, 1019, 10.1016/S0140-6736(10)61349-9 Banerjee, 2012, The macroeconomics of dementia – will the world economy get Alzheimer's disease?, Arch Med Res, 43, 705, 10.1016/j.arcmed.2012.10.006 Barrett-Connor, 1996, Weight loss precedes dementia in community-dwelling older adults, J Am Geriatr Soc, 44, 1147, 10.1111/j.1532-5415.1996.tb01362.x Barrio, 2015, In vivo characterization of chronic traumatic encephalopathy using [F-18]FDDNP PET brain imaging, Proc Natl Acad Sci U S A, 112, E2039, 10.1073/pnas.1409952112 Bartus, 1982, The cholinergic hypothesis of geriatric memory dysfunction, Science, 217, 408, 10.1126/science.7046051 Bateman, 2011, Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease, Alzheimers Res Ther, 3, 1, 10.1186/alzrt59 Beach, 2012, Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010, J Neuropathol Exp Neurol, 71, 266, 10.1097/NEN.0b013e31824b211b Bennett, 2010, Is there a link between cancer and Alzheimer disease?, Neurology, 74, 100, 10.1212/WNL.0b013e3181cbb89a Berchtold, 1998, Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s, Neurobiol Aging, 19, 173, 10.1016/S0197-4580(98)00052-9 Biessels, 2006, Risk of dementia in diabetes mellitus: a systematic review, Lancet Neurol, 5, 64, 10.1016/S1474-4422(05)70284-2 Birks, 2006, Cholinesterase inhibitors for Alzheimer's disease, Cochrane Database Syst Rev, 10.1002/14651858.CD005593 Boller, 1998, History of dementia and dementia in history: an overview, J Neurol Sci, 158, 125, 10.1016/S0022-510X(98)00128-2 Borjesson-Hanson, 2004, The prevalence of dementia in 95 year olds, Neurology, 63, 2436, 10.1212/01.WNL.0000147260.52841.27 Braak, 1995, Staging of Alzheimer's disease-related neurofibrillary changes, Neurobiol Aging, 16, 271, 10.1016/0197-4580(95)00021-6 Braak, 2015, The preclinical phase of the pathological process underlying sporadic Alzheimer's disease, Brain, 138, 2814, 10.1093/brain/awv236 Braak, 2011, Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years, J Neuropathol Exp Neurol, 70, 960, 10.1097/NEN.0b013e318232a379 Braak, 2013, Age-related appearance of dendritic inclusions in catecholaminergic brainstem neurons, Neurobiol Aging, 34, 286, 10.1016/j.neurobiolaging.2012.02.031 Brookmeyer, 1998, Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset, Am J Public Health, 88, 1337, 10.2105/AJPH.88.9.1337 Buckley, 2015, A risk-benefit assessment of dementia medications: systematic review of the evidence, Drugs Aging, 32, 453, 10.1007/s40266-015-0266-9 Bunch, 2010, Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia, Heart Rhythm, 7, 433, 10.1016/j.hrthm.2009.12.004 Burns, 2011, Replication study of genome-wide associated SNPs with late-onset Alzheimer's disease, Am J Med Genet B, 156B, 507, 10.1002/ajmg.b.31194 Byers, 2011, Depression and risk of developing dementia, Nat Rev Neurol, 7, 323, 10.1038/nrneurol.2011.60 Cacabelos, 2007, Donepezil in Alzheimer's disease: from conventional trials to pharmacogenetics, Neuropsychiatr Dis Treat, 3, 303 Carrillo, 2013, Can we prevent Alzheimer's disease? Secondary “prevention” trials in Alzheimer's disease, Alzheimers Dement, 9, 123, 10.1016/j.jalz.2012.12.004 Chartier-Harlin, 1991, Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene, Nature, 353, 844, 10.1038/353844a0 Chaudhry, 2010, Geriatric conditions and subsequent mortality in older patients with heart failure, J Am Coll Cardiol, 55, 309, 10.1016/j.jacc.2009.07.066 Chiang, 2010, Hippocampal atrophy rates and CSF biomarkers in elderly APOE2 normal subjects, Neurology, 75, 1976, 10.1212/WNL.0b013e3181ffe4d1 Chouraki, 2015, Plasma amyloid-beta and risk of Alzheimer's disease in the Framingham Heart Study, Alzheimers Dement, 11, 249, 10.1016/j.jalz.2014.07.001 Chui, 2012, Vascular risk factors and Alzheimer's disease: are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence-based review, Alzheimers Res Ther, 4, 1 Cobb, 1995, The effect of education on the incidence of dementia and Alzheimer's disease in the Framingham Study, Neurology, 45, 1707, 10.1212/WNL.45.9.1707 Cooper, 2013, Treatment for mild cognitive impairment: systematic review, Br J Psychiatry, 203, 255, 10.1192/bjp.bp.113.127811 Corey-Bloom, 2002, The ABC of Alzheimer's disease: cognitive changes and their management in Alzheimer's disease and related dementias, Int Psychogeriatr, 14, 51, 10.1017/S1041610203008664 CSHA Working-Group, 2000, The incidence of dementia in Canada. The Canadian Study of Health and Aging Working Group, Neurology, 55, 66 Cummings, 2015, A practical algorithm for managing Alzheimer's disease: what, when, and why?, Ann Clin Transl Neurol, 2, 307, 10.1002/acn3.166 Decarli, 2003, Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment, Lancet Neurol, 2, 15, 10.1016/S1474-4422(03)00262-X Deckers, 2015, Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies, Int J Geriatr Psychiatry, 30, 234, 10.1002/gps.4245 Ding, 2014, The Shanghai Aging Study: study design, baseline characteristics, and prevalence of dementia, Neuroepidemiology, 43, 114, 10.1159/000366163 Diniz, 2013, Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies, Br J Psychiatry, 202, 329, 10.1192/bjp.bp.112.118307 Dodge, 2012, Trends in the prevalence of dementia in Japan, Int J Alzheimers Dis, 2012, 956354 Driver, 2012, Inverse association between cancer and Alzheimer's disease: results from the Framingham Heart Study, BMJ, 344, e1442, 10.1136/bmj.e1442 Duthey, 2013 Ehret, 2015, Current practices in the treatment of Alzheimer disease: where is the evidence after the phase III trials?, Clin Ther, 37, 1604, 10.1016/j.clinthera.2015.05.510 Elias, 1993, Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study, Am J Epidemiol, 138, 353, 10.1093/oxfordjournals.aje.a116868 Ercoli, 2006, Perceived loss of memory ability and cerebral metabolic decline in persons with the apolipoprotein E-IV genetic risk for Alzheimer disease, Arch Gen Psychiatry, 63, 442, 10.1001/archpsyc.63.4.442 Eriksdotter-Jonhagen, 2012, Encapsulated cell biodelivery of nerve growth factor to the basal forebrain in patients with Alzheimer's disease, Dement Geriatr Cogn Disord, 33, 18, 10.1159/000336051 Erkinjuntti, 1997, The effect of different diagnostic criteria on the prevalence of dementia, N Engl J Med, 337, 1667, 10.1056/NEJM199712043372306 Evans, 1999, Women and Alzheimer disease, Alzheimer Dis Assoc Disord, 13, 187, 10.1097/00002093-199910000-00002 Farlow, 2015, Long-term treatment with active Abeta immunotherapy with CAD106 in mild Alzheimer's disease, Alzheimers Res Ther, 7, 23, 10.1186/s13195-015-0108-3 Fielding, 2011, The Lifestyle Interventions and Independence for Elders Study: design and methods, J Gerontol A Biol Sci Med Sci, 66, 1226, 10.1093/gerona/glr123 Fitzpatrick, 2004, Incidence and prevalence of dementia in the Cardiovascular Health Study, J Am Geriatr Soc, 52, 195, 10.1111/j.1532-5415.2004.52058.x Fitzpatrick, 2005, Survival following dementia onset: Alzheimer's disease and vascular dementia, J Neurol Sci, 229–230, 43, 10.1016/j.jns.2004.11.022 Fouquet, 2014, Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan, Neuropsychol Rev, 24, 290, 10.1007/s11065-014-9263-8 Fox, 2005, Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease, Neurology, 64, 1563, 10.1212/01.WNL.0000159743.08996.99 Fratiglioni, 1997, Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm, Neurology, 48, 132, 10.1212/WNL.48.1.132 Fratiglioni, 2000, Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group, Neurology, 54, S10 Frisardi, 2010, Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease, Ageing Res Rev, 9, 399, 10.1016/j.arr.2010.04.007 Gabryelewicz, 2007, The rate of conversion of mild cognitive impairment to dementia: predictive role of depression, Int J Geriatr Psychiatry, 22, 563, 10.1002/gps.1716 Ganguli, 2015, Cancer and dementia: it's complicated, Alzheimer Dis Assoc Disord, 29, 177, 10.1097/WAD.0000000000000086 Ganguli, 2000, Ten-year incidence of dementia in a rural elderly US community population: the MoVIES Project, Neurology, 54, 1109, 10.1212/WNL.54.5.1109 Ganguli, 2005, Alzheimer disease and mortality: a 15-year epidemiological study, Arch Neurol, 62, 779, 10.1001/archneur.62.5.779 Ganguli, 2005, Alcohol consumption and cognitive function in late life: a longitudinal community study, Neurology, 65, 1210, 10.1212/01.wnl.0000180520.35181.24 Garibotto, 2008, Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence, Neurology, 71, 1342, 10.1212/01.wnl.0000327670.62378.c0 Gatz, 2001, Education and the risk of Alzheimer's disease: findings from the study of dementia in Swedish twins, J Gerontol B Psychol Sci Soc Sci, 56, P292, 10.1093/geronb/56.5.P292 Gazzaley, 2005, Top-down suppression deficit underlies working memory impairment in normal aging, Nat Neurosci, 8, 1298, 10.1038/nn1543 Genin, 2011, APOE and Alzheimer disease: a major gene with semi-dominant inheritance, Mol Psychiatry, 16, 903, 10.1038/mp.2011.52 Gilman, 2005, Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial, Neurology, 64, 1553, 10.1212/01.WNL.0000159740.16984.3C Gold, 1997, Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia, Neurology, 49, 690, 10.1212/WNL.49.3.690 Graves, 1991, Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group, Int J Epidemiol, 20, S48, 10.1093/ije/20.Supplement_2.S48 Grinberg, 2009, The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?, Neuropathol Appl Neurobiol, 35, 406, 10.1111/j.1365-2990.2008.00997.x Grossberg, 2002, The ABC of Alzheimer's disease: behavioral symptoms and their treatment, Int Psychogeriatr, 14, 27, 10.1017/S1041610203008652 Guo, 1999, Low blood pressure and incidence of dementia in a very old sample: dependent on initial cognition, J Am Geriatr Soc, 47, 723, 10.1111/j.1532-5415.1999.tb01597.x Guo, 2007, Midlife respiratory function and Incidence of Alzheimer's disease: a 29-year longitudinal study in women, Neurobiol Aging, 28, 343, 10.1016/j.neurobiolaging.2006.01.008 Gustafson, 2010, Adipose tissue, inflammation and atherosclerosis, J Atheroscler Thromb, 17, 332, 10.5551/jat.3939 Gustafson, 2003, An 18-year follow-up of overweight and risk of Alzheimer disease, Arch Intern Med, 163, 1524, 10.1001/archinte.163.13.1524 Gustafson, 2015, New perspectives on Alzheimer's disease and nutrition, J Alzheimers Dis, 46, 1111, 10.3233/JAD-150084 Haass, 1999, The presenilins in Alzheimer's disease – proteolysis holds the key, Science, 286, 916, 10.1126/science.286.5441.916 Hardy, 1992, Alzheimer's disease: the amyloid cascade hypothesis, Science, 256, 184, 10.1126/science.1566067 Hassing, 2002, Diabetes mellitus is a risk factor for vascular dementia, but not for Alzheimer's disease: a population-based study of the oldest old, Int Psychogeriatr, 14, 239, 10.1017/S104161020200844X Hassing, 2004, Type 2 diabetes mellitus contributes to cognitive decline in old age: a longitudinal population-based study, J Int Neuropsychol Soc, 10, 599, 10.1017/S1355617704104165 Henderson, 2010, Action of estrogens in the aging brain: dementia and cognitive aging, Biochim Biophys Acta, 1800, 1077, 10.1016/j.bbagen.2009.11.005 Heneka, 2015, Neuroinflammation in Alzheimer's disease, Lancet Neurol, 14, 388, 10.1016/S1474-4422(15)70016-5 Herrup, 2015, The case for rejecting the amyloid cascade hypothesis, Nat Neurosci, 18, 794, 10.1038/nn.4017 Heyman, 1997, Predictors of time to institutionalization of patients with Alzheimer's disease: the CERAD experience, part XVII, Neurology, 48, 1304, 10.1212/WNL.48.5.1304 Holmes, 2008, Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial, Lancet, 372, 216, 10.1016/S0140-6736(08)61075-2 Honda, 2004, Oxidative stress and redox-active iron in Alzheimer's disease, Ann N Y Acad Sci, 1012, 179, 10.1196/annals.1306.015 Hooshmand, 2010, Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study, Neurology, 75, 1408, 10.1212/WNL.0b013e3181f88162 Houde, 2008, A predictive depression pattern in mild cognitive impairment, Int J Geriatr Psychiatry, 23, 1028, 10.1002/gps.2028 Howard, 2012, Donepezil and memantine for moderate-to-severe Alzheimer's disease, N Engl J Med, 366, 893, 10.1056/NEJMoa1106668 Huang, 2014, Diabetes mellitus and the risk of Alzheimer's disease: a nationwide population-based study, PLoS One, 9, e87095, 10.1371/journal.pone.0087095 Hurd, 2015, Future monetary costs of dementia in the United States under alternative dementia prevalence scenarios, J Popul Ageing, 8, 101, 10.1007/s12062-015-9112-4 Irie, 2008, Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study, Arch Neurol, 65, 89, 10.1001/archneurol.2007.29 Irie, 2008, Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: the Honolulu-Asia Aging Study, Arch Gen Psychiatry, 65, 906, 10.1001/archpsyc.65.8.906 Jack, 2011, Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimers Dement, 7, 257, 10.1016/j.jalz.2011.03.004 Jack, 2013, Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers, Lancet Neurol, 12, 207, 10.1016/S1474-4422(12)70291-0 Jagger, 2000, Prognosis with dementia in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group, Neurology, 54, S16 Jellinger, 2010, Prevalence of dementia disorders in the oldest-old: an autopsy study, Acta Neuropathol, 119, 421, 10.1007/s00401-010-0654-5 Johansson, 2010, Midlife psychological stress and risk of dementia: a 35-year longitudinal population study, Brain, 133, 2217, 10.1093/brain/awq116 Johansson, 2013, Common psychosocial stressors in middle-aged women related to longstanding distress and increased risk of Alzheimer's disease: a 38-year longitudinal population study, BMJ open, 3, e003142, 10.1136/bmjopen-2013-003142 Jorm, 1998, The incidence of dementia: a meta-analysis, Neurology, 51, 728, 10.1212/WNL.51.3.728 Jorm, 1987, The prevalence of dementia: a quantitative integration of the literature, Acta Psychiatr Scand, 76, 465, 10.1111/j.1600-0447.1987.tb02906.x Jorm, 2005, Projections of future numbers of dementia cases in Australia with and without prevention, Aust N Z J Psychiatry, 39, 959, 10.1080/j.1440-1614.2005.01713.x Kalaria, 2008, Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors, Lancet Neurol, 7, 812, 10.1016/S1474-4422(08)70169-8 Karp, 2004, Relation of educa tion and occupation-based socioeconomic status to incident Alzheimer's disease, Am J Epidemiol, 159, 175, 10.1093/aje/kwh018 Karran, 2011, The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics, Nat Rev Drug Discov, 10, 698, 10.1038/nrd3505 Kawas, 2000, Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging, Neurology, 54, 2072, 10.1212/WNL.54.11.2072 Kemppainen, 2008, Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease, Ann Neurol, 63, 112, 10.1002/ana.21212 Kim, 2015, Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome, Exp Mol Med, 47, e149, 10.1038/emm.2015.3 Kivipelto, 2005, Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease, Arch Neurol, 62, 1556, 10.1001/archneur.62.10.1556 Kivipelto, 2006, Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study, Lancet Neurol, 5, 735, 10.1016/S1474-4422(06)70537-3 Kokmen, 1993, Is the incidence of dementing illness changing? A 25-year time trend study in Rochester, Minnesota (1960–1984), Neurology, 43, 1887, 10.1212/WNL.43.10.1887 Kua, 2014, The natural history of dementia, Psychogeriatrics, 14, 196, 10.1111/psyg.12053 Kukull, 2002, Dementia and Alzheimer disease incidence: a prospective cohort study, Arch Neurol, 59, 1737, 10.1001/archneur.59.11.1737 Lambert, 2011, Genetics of Alzheimer's disease: new evidences for an old hypothesis?, Curr Opin Genet Dev, 21, 295, 10.1016/j.gde.2011.02.002 Lambert, 2014, Estimating the burden of early onset dementia; systematic review of disease prevalence, Eur J Neurol, 21, 563, 10.1111/ene.12325 Lambracht-Washington, 2013, Anti-amyloid beta to tau-based immunization: developments in immunotherapy for Alzheimer disease, Immuno Targets Ther, 2013, 105, 10.2147/ITT.S31428 Lane, 2004, Acetylcholinesterase and its inhibition in Alzheimer disease, Clin Neuropharmacol, 27, 141, 10.1097/00002826-200405000-00011 Langa, 2008, Trends in the prevalence and mortality of cognitive impairment in the United States: is there evidence of a compression of cognitive morbidity?, Alzheimers Dement, 4, 134, 10.1016/j.jalz.2008.01.001 Launer, 1999, Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia, Neurology, 52, 78, 10.1212/WNL.52.1.78 Lee, 2012, Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimer's disease-related regions, Biol Psychiatry, 71, 814, 10.1016/j.biopsych.2011.12.024 Lepreux, 2015, Dementia pugilistica: a severe tribute to a career, Clin Neuropathol, 34, 193, 10.5414/NP300838 Letenneur, 2004, Alcohol and tobacco consumption as risk factors of dementia: a review of epidemiological studies, Biomed Pharmacother, 58, 95, 10.1016/j.biopha.2003.12.004 Li, 2011, Temporal relationship between depression and dementia: findings from a large community-based 15-year follow-up study, Arch Gen Psychiatry, 68, 970, 10.1001/archgenpsychiatry.2011.86 Li, 2014, Efficacy of vitamins B supplementation on mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis, Curr Alzheimer Res, 11, 844 Liao, 2015, The association between chronic obstructive pulmonary disease and dementia: a population-based retrospective cohort study, Eur J Neurol, 22, 334, 10.1111/ene.12573 Llewellyn, 2009, Increasing levels of semantic verbal fluency in elderly English adults, Neuropsychol Dev Cogn B Aging Neuropsychol Cogn, 16, 433, 10.1080/13825580902773867 Llibre Rodriguez, 2008, The prevalence, correlates and impact of dementia in Cuba. A 10/66 group population-based survey, Neuroepidemiology, 31, 243, 10.1159/000165362 Lobo, 2007, Prevalence of dementia in a southern European population in two different time periods: the ZARADEMP Project, Acta Psychiatr Scand, 116, 299, 10.1111/j.1600-0447.2007.01006.x Lucca, 2015, Prevalence of dementia in the oldest old: the Monzino 80-plus population based study, Alzheimers Dement, 11, 258, 10.1016/j.jalz.2014.05.1750 Magri, 2006, Stress and dementia: the role of the hypothalamic–pituitary-adrenal axis, Aging Clin Exp Res, 18, 167, 10.1007/BF03327435 Mahley, 2012, Apolipoprotein e sets the stage: response to injury triggers neuropathology, Neuron, 76, 871, 10.1016/j.neuron.2012.11.020 Malouf, 2003, Vitamin B12 for cognition, Cochrane Database Syst Rev, CD004326 Mangialasche, 2010, Alzheimer's disease: clinical trials and drug development, Lancet Neurol, 9, 702, 10.1016/S1474-4422(10)70119-8 Matthews, 2013, A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II, Lancet, 382, 1405, 10.1016/S0140-6736(13)61570-6 McGuinness, 2009, Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia, Cochrane Database Syst Rev, 10.1002/14651858.CD004034.pub3 McKhann, 1984, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 McKhann, 2011, The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimers Dement, 7, 263, 10.1016/j.jalz.2011.03.005 McShane, 2006, Memantine for dementia, Cochrane Database Syst Rev, 10.1002/14651858.CD003154.pub5 Mehlig, 2008, Alcoholic beverages and incidence of dementia: 34-year follow-up of the prospective population study of women in Goteborg, Am J Epidemiol, 167, 684, 10.1093/aje/kwm366 Mielke, 2005, High total cholesterol levels in late life associated with a reduced risk of dementia, Neurology, 64, 1689, 10.1212/01.WNL.0000161870.78572.A5 Mielke, 2010, The 32-year relationship between cholesterol and dementia from midlife to late life, Neurology, 75, 1888, 10.1212/WNL.0b013e3181feb2bf Mirra, 1991, The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease, Neurology, 41, 479, 10.1212/WNL.41.4.479 Misiak, 2013, European studies on the prevalence of dementia in the elderly: time for a step towards a methodological consensus, Int J Geriatr Psychiatry, 28, 1211, 10.1002/gps.3948 Mitchell, 2002, Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease, Ann Neurol, 51, 182, 10.1002/ana.10086 Modrego, 2004, Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study, Arch Neurol, 61, 1290, 10.1001/archneur.61.8.1290 Morris, 1993, The Clinical Dementia Rating (CDR): current version and scoring rules, Neurology, 43, 2412, 10.1212/WNL.43.11.2412-a Morris, 2012, The role of B vitamins in preventing and treating cognitive impairment and decline, Adv Nutr, 3, 801, 10.3945/an.112.002535 Morris, 2006, Dietary folate and vitamins B-12 and B-6 not associated with incident Alzheimer's disease, J Alzheimers Dis, 9, 435, 10.3233/JAD-2006-9410 Mortimer, 1991, Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group, Int J Epidemiol, 20, S28, 10.1093/ije/20.Supplement_2.S28 Mosconi, 2008, Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias, J Nucl Med, 49, 390, 10.2967/jnumed.107.045385 Nelson, 2012, Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature, J Neuropathol Exp Neurol, 71, 362, 10.1097/NEN.0b013e31825018f7 Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC-CFAS), 2001, Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales, Lancet, 357, 169, 10.1016/S0140-6736(00)03589-3 Newell, 1999, Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease, J Neuropathol Exp Neurol, 58, 1147, 10.1097/00005072-199911000-00004 Ngandu, 2015, A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial, Lancet, 385, 2255, 10.1016/S0140-6736(15)60461-5 Nierenberg, 2005, Abnormal white matter integrity in healthy apolipoprotein E epsilon4 carriers, Neuroreport, 16, 1369, 10.1097/01.wnr.0000174058.49521.16 Nobili, 2008, Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study, J Neurol, 255, 1344, 10.1007/s00415-008-0897-4 Nordstrom, 2014, Traumatic brain injury and young onset dementia: a nationwide cohort study, Ann Neurol, 75, 374, 10.1002/ana.24101 Norton, 2013, A commentary on studies presenting projections of the future prevalence of dementia, BMC Public Health, 13, 1, 10.1186/1471-2458-13-1 Norton, 2014, Potential for primary prevention of Alzheimer's disease: an analysis of population-based data, Lancet Neurol, 13, 788, 10.1016/S1474-4422(14)70136-X Olazaran, 2010, Nonpharmacological therapies in Alzheimer's disease: a systematic review of efficacy, Dement Geriatr Cogn Disord, 30, 161, 10.1159/000316119 O'Meara, 1997, Head injury and risk of Alzheimer's disease by apolipoprotein E genotype, Am J Epidemiol, 146, 373, 10.1093/oxfordjournals.aje.a009290 Orgogozo, 1997, Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area, Rev Neurol, 153, 185 Ott, 1999, Diabetes mellitus and the risk of dementia: the Rotterdam Study, Neurology, 53, 1937, 10.1212/WNL.53.9.1937 Ott, 2004, Effect of smoking on global cognitive function in nondemented elderly, Neurology, 62, 920, 10.1212/01.WNL.0000115110.35610.80 Ownby, 2006, Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis, Arch Gen Psychiatry, 63, 530, 10.1001/archpsyc.63.5.530 Palmer, 2008, Mild cognitive impairment in the general population: occurrence and progression to Alzheimer disease, Am J Geriatr Psychiatry, 16, 603, 10.1097/JGP.0b013e3181753a64 Palsson, 1999, Depression, cerebral atrophy, cognitive performance and incidence of dementia. Population study of 85-year-olds, Br J Psychiatry, 174, 249, 10.1192/bjp.174.3.249 Panza, 2010, Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms, J Alzheimers Dis, 21, 691, 10.3233/JAD-2010-091669 Perls, 2004, Dementia-free centenarians, Exp Gerontol, 39, 1587, 10.1016/j.exger.2004.08.015 Petersen, 2011, Clinical practice. Mild cognitive impairment, N Engl J Med, 364, 2227, 10.1056/NEJMcp0910237 Petersen, 1999, Mild cognitive impairment: clinical characterization and outcome, Arch Neurol, 56, 303, 10.1001/archneur.56.3.303 Pimouguet, 2015, Effect of early referral to specialist in dementia on institutionalization and functional decline: findings from a population-based study, J Alzheimers Dis, 49, 819, 10.3233/JAD-150574 Plassman, 2007, Prevalence of dementia in the United States: the aging, demographics, and memory study, Neuroepidemiology, 29, 125, 10.1159/000109998 Polvikoski, 2001, Prevalence of Alzheimer's disease in very elderly people: a prospective neuropathological study, Neurology, 56, 1690, 10.1212/WNL.56.12.1690 Polvikoski, 2006, Incidence of dementia in very elderly individuals: a clinical, neuropathological and molecular genetic study, Neuroepidemiology, 26, 76, 10.1159/000090252 Poon, 2012, Understanding dementia prevalence among centenarians, J Gerontol A Biol Sci Med Sci, 67, 358, 10.1093/gerona/glr250 Potkin, 2002, The ABC of Alzheimer's disease: ADL and improving day-to-day functioning of patients, Int Psychogeriatr, 14, 7, 10.1017/S1041610203008640 Prince, 2003, Dementia diagnosis in developing countries: a cross-cultural validation study, Lancet, 361, 909, 10.1016/S0140-6736(03)12772-9 Prince, 2007, The protocols for the 10/66 dementia research group population-based research programme, BMC Public Health, 7, 165, 10.1186/1471-2458-7-165 Prince, 2012, Dementia incidence and mortality in middle-income countries, and associations with indicators of cognitive reserve: a 10/66 Dementia Research Group population-based cohort study, Lancet, 380, 50, 10.1016/S0140-6736(12)60399-7 Prince, 2013, The global prevalence of dementia: a systematic review and metaanalysis, Alzheimers Dement, 9, 63, 10.1016/j.jalz.2012.11.007 Prins, 2002, Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study, Neurology, 59, 1375, 10.1212/01.WNL.0000032494.05619.93 Putter, 2007, Tutorial in biostatistics: competing risks and multi-state models, Stat Med, 26, 2389, 10.1002/sim.2712 Puzzo, 2015, The keystone of Alzheimer pathogenesis might be sought in Abeta physiology, Neuroscience, 307, 26, 10.1016/j.neuroscience.2015.08.039 Qiu, 2003, Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study, Arch Neurol, 60, 223, 10.1001/archneur.60.2.223 Qiu, 2004, Decline in blood pressure over time and risk of dementia: a longitudinal study from the Kungsholmen project, Stroke, 35, 1810, 10.1161/01.STR.0000133128.42462.ef Qiu, 2005, The age-dependent relation of blood pressure to cognitive function and dementia, Lancet Neurol, 4, 487, 10.1016/S1474-4422(05)70141-1 Qureshi, 2010, Greater prevalence and incidence of dementia in older veterans with posttraumatic stress disorder, J Am Geriatr Soc, 58, 1627, 10.1111/j.1532-5415.2010.02977.x Reay, 2013, B vitamins and cognitive performance in older adults: review, ISRN Nutr, 2013, 650983, 10.5402/2013/650983 Reiman, 2009, Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease, Proc Natl Acad Sci U S A, 106, 6820, 10.1073/pnas.0900345106 Rentz, 2010, Cognition, reserve, and amyloid deposition in normal aging, Ann Neurol, 67, 353 Richard, 2012, Methodological challenges in designing dementia prevention trials – the European Dementia Prevention Initiative (EDPI), J Neurol Sci, 322, 64, 10.1016/j.jns.2012.06.012 Ritchie, 1995, Is senile dementia “age-related” or “ageing-related”? Evidence from meta-analysis of dementia prevalence in the oldest old, Lancet, 346, 931, 10.1016/S0140-6736(95)91556-7 Ritchie, 2001, Classification criteria for mild cognitive impairment: a population-based validation study, Neurology, 56, 37, 10.1212/WNL.56.1.37 Rocca, 2011, Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States, Alzheimers Dement, 7, 80, 10.1016/j.jalz.2010.11.002 Rockwood, 1996, High blood pressure and dementia, Lancet, 348, 65, 10.1016/S0140-6736(05)64396-6 Roe, 2010, Cancer linked to Alzheimer disease but not vascular dementia, Neurology, 74, 106, 10.1212/WNL.0b013e3181c91873 Rolinski, 2012, Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease, Cochrane Database Syst Rev, 3, CD006504 Ruitenberg, 2002, Alcohol consumption and risk of dementia: the Rotterdam Study, Lancet, 359, 281, 10.1016/S0140-6736(02)07493-7 Rusanen, 2010, Midlife smoking, apolipoprotein E and risk of dementia and Alzheimer's disease: a population-based cardiovascular risk factors, aging and dementia study, Dement Geriatr Cogn Disord, 30, 277, 10.1159/000320484 Rusanen, 2011, Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia, Arch Intern Med, 171, 333, 10.1001/archinternmed.2010.393 Sachdev, 2000, Is it time to retire the term “dementia”?, J Neuropsychiatry Clin Neurosci, 12, 276, 10.1176/jnp.12.2.276 Sachdev, 2014, Classifying neurocognitive disorders: the DSM-5 approach, Nat Rev Neurol, 10, 634, 10.1038/nrneurol.2014.181 Sacuiu, 2005, Prodromal cognitive signs of dementia in 85-year-olds using four sources of information, Neurology, 65, 1894, 10.1212/01.wnl.0000188873.13444.85 Sacuiu, 2009, The pattern of cognitive symptoms predicts time to dementia onset, Alzheimers Dement, 5, 199, 10.1016/j.jalz.2008.10.007 Sacuiu, 2010, Secular changes in cognitive predictors of dementia and mortality in 70-year-olds, Neurology, 75, 779, 10.1212/WNL.0b013e3181f0737c Sacuiu, 2016, Chronic depressive symptomatology in mild cognitive impairment is associated with frontal atrophy rate which hastens conversion to Alzheimer dementia, Am J Geriatr Psychiatry, 24, 126, 10.1016/j.jagp.2015.03.006 Sadowski, 2004, Links between the pathology of Alzheimer's disease and vascular dementia, Neurochem Res, 29, 1257, 10.1023/B:NERE.0000023612.66691.e6 Salloway, 2014, Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease, N Engl J Med, 370, 322, 10.1056/NEJMoa1304839 Sarter, 2004, Developmental origins of the age-related decline in cortical cholinergic function and associated cognitive abilities, Neurobiol Aging, 25, 1127, 10.1016/j.neurobiolaging.2003.11.011 Schaie, 1993, Age difference patterns of psychometric intelligence in adulthood: generalizability within and across ability domains, Psychol Aging, 8, 44, 10.1037/0882-7974.8.1.44 Schaie, 2005, An historical framework for cohort differences in intelligence, Res Hum Dev, 2, 43, 10.1080/15427609.2005.9683344 Schneider, 2003, Relation of cerebral infarctions to dementia and cognitive function in older persons, Neurology, 60, 1082, 10.1212/01.WNL.0000055863.87435.B2 Schuff, 2007, Imaging of mild cognitive impairment and early dementia, Br J Radiol, 80, S109, 10.1259/bjr/63830887 Selkoe, 2000, Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein, Ann N Y Acad Sci, 924, 17, 10.1111/j.1749-6632.2000.tb05554.x Seshadri, 2002, Plasma homocysteine as a risk factor for dementia and Alzheimer's disease, N Engl J Med, 346, 476, 10.1056/NEJMoa011613 Severson, 1994, Patterns and predictors of institutionalization in community-based dementia patients, J Am Geriatr Soc, 42, 181, 10.1111/j.1532-5415.1994.tb04949.x Sherrington, 1995, Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease, Nature, 375, 754, 10.1038/375754a0 Sink, 2014, The LIFE Cognition Study: design and baseline characteristics, Clin Interv Aging, 9, 1425, 10.2147/CIA.S65381 Skoog, 1998, Status of risk factors for vascular dementia, Neuroepidemiology, 17, 2, 10.1159/000026147 Skoog, 1993, A population-based study of dementia in 85-year-olds, N Engl J Med, 328, 153, 10.1056/NEJM199301213280301 Skoog, 1996, 15-year longitudinal study of blood pressure and dementia, Lancet, 347, 1141, 10.1016/S0140-6736(96)90608-X Slooter, 1998, Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study, Arch Neurol, 55, 964, 10.1001/archneur.55.7.964 Slooter, 1998, Apolipoprotein E genotype, atherosclerosis, and cognitive decline: the Rotterdam Study, J Neural Transm Suppl, 53, 17, 10.1007/978-3-7091-6467-9_3 Small, 2008, Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis, Neuron, 60, 534, 10.1016/j.neuron.2008.11.007 Small, 2004, Apolipoprotein E and cognitive performance: a meta-analysis, Psychol Aging, 19, 592, 10.1037/0882-7974.19.4.592 Small, 2006, PET of brain amyloid and tau in mild cognitive impairment, N Engl J Med, 355, 2652, 10.1056/NEJMoa054625 Smith, 2008, The worldwide challenge of the dementias: a role for B vitamins and homocysteine?, Food Nutr Bull, 29, S143, 10.1177/15648265080292S119 Solomon, 2009, Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later, Dement Geriatr Cogn Disord, 28, 75, 10.1159/000231980 Stampfer, 2005, Effects of moderate alcohol consumption on cognitive function in women, N Engl J Med, 352, 245, 10.1056/NEJMoa041152 Stern, 1998, Increased risk of mortality in AD patients with higher education?, Neurology, 51, 1238, 10.1212/WNL.51.4.1238-a Stern, 1994, Influence of education and occupation on the incidence of Alzheimer's disease, JAMA, 271, 1004, 10.1001/jama.1994.03510370056032 Stern, 1995, Increased risk of mortality in Alzheimer's disease patients with more advanced educational and occupational attainment, Ann Neurol, 37, 590, 10.1002/ana.410370508 Stern, 2003, Exploring the neural basis of cognitive reserve, J Clin Exp Neuropsychol, 25, 691, 10.1076/jcen.25.5.691.14573 Stewart, 2009, Change in blood pressure and incident dementia: a 32-year prospective study, Hypertension, 54, 233, 10.1161/HYPERTENSIONAHA.109.128744 Storey, 2002, Patterns of cognitive impairment in Alzheimer's disease: assessment and differential diagnosis, Front Biosci, 7, e155 Tanzi, 2005, Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective, Cell, 120, 545, 10.1016/j.cell.2005.02.008 Tateno, 2015, A case of Alzheimer's disease following mild traumatic brain injury, Gen Hosp Psychiatry, 37, 10.1016/j.genhosppsych.2014.09.016 Terry, 2001, Life span and synapses: will there be a primary senile dementia?, Neurobiol Aging, 22, 347, 10.1016/S0197-4580(00)00250-5 Tierney, 1988, The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases, Neurology, 38, 359, 10.1212/WNL.38.3.359 Tola-Arribas, 2013, Prevalence of dementia and subtypes in Valladolid, northwestern Spain: the DEMINVALL study, PLoS One, 8, e77688, 10.1371/journal.pone.0077688 Truelsen, 2002, Amount and type of alcohol and risk of dementia: the Copenhagen City Heart Study, Neurology, 59, 1313, 10.1212/01.WNL.0000031421.50369.E7 Velazquez-Brizuela, 2014, Prevalence of dementia, emotional state and physical performance among older adults in the metropolitan area of Guadalajara, Jalisco, Mexico, Curr Gerontol Geriatr Res, 2014, 387528, 10.1155/2014/387528 Vellas, 2013, Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force, Alzheimers Dement, 9, 438, 10.1016/j.jalz.2013.03.007 Verghese, 2003, Low blood pressure and the risk of dementia in very old individuals, Neurology, 61, 1667, 10.1212/01.WNL.0000098934.18300.BE Vickland, 2010, A computer model of dementia prevalence in Australia: foreseeing outcomes of delaying dementia onset, slowing disease progression, and eradicating dementia types, Dement Geriatr Cogn Disord, 29, 123, 10.1159/000272436 Villemagne, 2013, Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study, Lancet Neurol, 12, 357, 10.1016/S1474-4422(13)70044-9 Visser, 2006, Ten-year risk of dementia in subjects with mild cognitive impairment, Neurology, 67, 1201, 10.1212/01.wnl.0000238517.59286.c5 Visser, 2009, Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study, Lancet Neurol, 8, 619, 10.1016/S1474-4422(09)70139-5 Von Strauss, 1999, Aging and the occurrence of dementia: findings from a population-based cohort with a large sample of nonagenarians, Arch Neurol, 56, 587, 10.1001/archneur.56.5.587 Wancata, 2007, Diagnostic criteria influence dementia prevalence, Am J Geriatr Psychiatry, 15, 1034, 10.1097/JGP.0b013e31813c6b6c Wang, 2012, Education halves the risk of dementia due to apolipoprotein epsilon4 allele: a collaborative study from the Swedish brain power initiative, Neurobiol Aging, 33, 10.1016/j.neurobiolaging.2011.10.003 Wang, 2012, Psychosocial stress at work is associated with increased dementia risk in late life, Alzheimers Dement, 8, 114, 10.1016/j.jalz.2011.03.001 Watson, 2003, The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment, CNS Drugs, 17, 27, 10.2165/00023210-200317010-00003 White, 1996, Weight change in Alzheimer's disease, J Am Geriatr Soc, 44, 265, 10.1111/j.1532-5415.1996.tb00912.x Whitmer, 2007, Body mass index in midlife and risk of Alzheimer disease and vascular dementia, Curr Alzheimer Res, 4, 103, 10.2174/156720507780362047 WHO, 2012 Wiberg, 2013, Secular trends in the prevalence of dementia and depression in Swedish septuagenarians 1976–2006, Psychol Med, 43, 2627, 10.1017/S0033291713000299 Wilson, 2002, The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period, Arch Neurol, 59, 1154, 10.1001/archneur.59.7.1154 Winblad, 2004, Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment, J Intern Med, 256, 240, 10.1111/j.1365-2796.2004.01380.x Winblad, 2012, Safety, tolerability, and antibody response of active Abeta immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study, Lancet Neurol, 11, 597, 10.1016/S1474-4422(12)70140-0 Wisniewski, 2008, Amyloid-beta immunisation for Alzheimer's disease, Lancet Neurol, 7, 805, 10.1016/S1474-4422(08)70170-4 Withall, 2014, The prevalence and causes of younger onset dementia in Eastern Sydney, Australia, Int Psychogeriatr, 26, 1955, 10.1017/S1041610214001835 World Health Organization, 2010 Wu, 2013, Prevalence studies of dementia in mainland china, Hong Kong and taiwan: a systematic review and meta-analysis, PLoS One, 8 Wu, 2016, Dementia in western Europe: epidemiological evidence and implications for policy making, Lancet Neurol, 15, 116, 10.1016/S1474-4422(15)00092-7 Xie, 2008, Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up, BMJ, 336, 258, 10.1136/bmj.39433.616678.25 Xie, 2012, The co-existence of geriatric depression and amnestic mild cognitive impairment detrimentally affect gray matter volumes: voxel-based morphometry study, Behav Brain Res, 235, 244, 10.1016/j.bbr.2012.08.007 Xu, 2009, Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study, Diabetes, 58, 71, 10.2337/db08-0586 Xu, 2009, Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study, Diabetologia, 52, 1031, 10.1007/s00125-009-1323-x Yaffe, 2010, Posttraumatic stress disorder and risk of dementia among US veterans, Arch Gen Psychiatry, 67, 608, 10.1001/archgenpsychiatry.2010.61 Yan, 2014, Targeting the beta secretase BACE1 for Alzheimer's disease therapy, Lancet Neurol, 13, 319, 10.1016/S1474-4422(13)70276-X Yang, 2013, Effectiveness and safety of memantine treatment for Alzheimer's disease, J Alzheimers Dis, 36, 445, 10.3233/JAD-130395 Zaccai, 2006, Population-based neuropathological studies of dementia: design, methods and areas of investigation—a systematic review, BMC Neurol, 6, 2, 10.1186/1471-2377-6-2 Zhu, 2000, Incidence of dementia in relation to stroke and the apolipoprotein E epsilon4 allele in the very old. Findings from a population-based longitudinal study, Stroke, 31, 53, 10.1161/01.STR.31.1.53 Ziegler-Graham, 2008, Worldwide variation in the doubling time of Alzheimer's disease incidence rates, Alzheimers Dement, 4, 316, 10.1016/j.jalz.2008.05.2479 Zylberstein, 2011, Midlife homocysteine and late-life dementia in women. A prospective population study, Neurobiol Aging, 32, 380, 10.1016/j.neurobiolaging.2009.02.024